Showing 1 - 20 results of 23 for search 'Diwakar Davar', query time: 0.49s Refine Results
  1. 1
    Adjuvant Therapy: Melanoma
    by Diwakar Davar, Ahmad Tarhini, John M. Kirkwood
    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features.
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    394 Interleukin-8–neutralizing monoclonal antibody BMS-986253 plus nivolumab (NIVO) in biomarker-enriched, primarily anti–PD-(L)1–experienced patients with advanced cancer: initial phase 1 results
    Article
    Save to List
    Saved in:
  9. 9
    474 Phase 1 study of SEA-TGT, a human, nonfucosylated anti-TIGIT monoclonal antibody with enhanced immune-effector function, in patients with advanced malignancies (SGNTGT-001, trial in progress)
    Article
    Save to List
    Saved in:
  10. 10
    1322 Too sweet to be true: sucralose ablates immunotherapy response through microbiome disruption
    Article
    Save to List
    Saved in:
  11. 11
    596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 therapy
    Article
    Save to List
    Saved in:
  12. 12
    782 TransCon TLR7/8 agonist induces sustained local and systemic immune activation in patients with solid tumors
    Article
    Save to List
    Saved in:
  13. 13
    Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    888 Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma
    Article
    Save to List
    Saved in:
  15. 15
    Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melanoma
    Article
    Save to List
    Saved in:
  18. 18
    777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS)
    Article
    Save to List
    Saved in:
  19. 19
    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial
    Article
    Save to List
    Saved in:
Search Tools: RSS Feed – Email Search